Trial intelligence / Profile preview

Efficacy of Nesiritide in Decompensated CHF

NCT00288730Phase 3Completed

Sponsor
Scios Inc.
Start
Oct 1996
Modality
Recombinant Proteins and Enzymes
01

Overview

A Phase 3 trial of nesiritide in heart failure (HF), sponsored by Scios Inc.. Started Oct 1996; status: completed.

02

Drugs

nesiritide
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00288730.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00288730.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call